Dan-Yu Lin
Overview
Explore the profile of Dan-Yu Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
4190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Wong K, Howard A, Gordon-Larsen P, Highland H, Graff M, et al.
HGG Adv
. 2024 Aug;
5(4):100338.
PMID: 39095990
Multivariable Mendelian randomization allows simultaneous estimation of direct causal effects of multiple exposure variables on an outcome. When the exposure variables of interest are quantitative omic features, obtaining complete data...
2.
Lin D, Wang J, Anstrom K, LaVange L, Wen J, Bozzette S, et al.
Int J Infect Dis
. 2024 Jul;
146:107168.
PMID: 38977241
A randomized, double-blind, placebo-controlled clinical trial was conducted to investigate the efficacy of infliximab, abatacept, and cenicriviroc in treating patients hospitalized with COVID-19. The patient's clinical status was assessed daily...
3.
Lin D, Du Y, Xu Y, Paritala S, Donahue M, Maloney P
N Engl J Med
. 2024 May;
390(22):2124-2127.
PMID: 38810167
No abstract available.
4.
Lin D, Xu Y, Gu Y, Sunny S, Moore Z, Zeng D
Int J Infect Dis
. 2024 May;
145:107084.
PMID: 38705567
Objectives: We investigated how booster interval affects the risks of SARS-CoV-2 infection and Covid-19-related hospitalization and death in different age groups. Methods: We collected data on booster receipts and Covid-19...
5.
Lin D, Wang J, Gu Y, Zeng D
Clin Trials
. 2024 Apr;
21(4):500-506.
PMID: 38618926
Background: The current endpoints for therapeutic trials of hospitalized COVID-19 patients capture only part of the clinical course of a patient and have limited statistical power and robustness. Methods: We...
6.
Wang J, Zeng D, Lin D
Biometrics
. 2024 Mar;
80(1).
PMID: 38497824
The semiparametric Cox proportional hazards model, together with the partial likelihood principle, has been widely used to study the effects of potentially time-dependent covariates on a possibly censored event time....
7.
Lin D, Huang S, Milinovich A, Duggal A, Wang X
Lancet Infect Dis
. 2024 Mar;
24(5):e278-e280.
PMID: 38452778
No abstract available.
8.
Xu Y, Zeng D, Lin D
Biometrics
. 2024 Feb;
80(1).
PMID: 38364799
Multivariate panel count data arise when there are multiple types of recurrent events, and the observation for each study subject consists of the number of recurrent events of each type...
9.
Lin D, Xu Y, Zeng D, Sunny S
J Biotechnol Biomed
. 2023 Dec;
6(4):551-553.
PMID: 38050633
No abstract available.
10.
Li Y, Wong K, Howard A, Gordon-Larsen P, Highland H, Graff M, et al.
HGG Adv
. 2023 Oct;
5(1):100245.
PMID: 37817410
Mendelian randomization has been widely used to assess the causal effect of a heritable exposure variable on an outcome of interest, using genetic variants as instrumental variables. In practice, data...